Concurrent treatment of obstructive sleep apnea and hypertension in a patient, via a pressure generating system, includes providing a flow of treatment gas to an airway of a patient in accordance with an initial set of flow parameters with respect to an obstructive sleep apnea mode. Responsive to determining that the patient has achieved stable breathing while receiving the flow of treatment gas, the flow parameters are increased above the initial set of flow parameters with respect to a hyper-ventilation mode. The flow of treatment gas is then provided to the airway of the patient in accordance with the increased flow parameters for a predetermined period of time. The increased flow parameters are configured to bring the patient's breath into accordance with target patient breath parameters configured to inflate the patient's lungs beyond a threshold for activating pulmonary stretch receptors of the airway of the patient.

Concurrent treatment of obstructive sleep apnea and hypertension in a patient, via a pressure generating system, includes providing a flow of treatment gas to an airway of a patient in accordance with an initial set of flow parameters with respect to an obstructive sleep apnea mode. Responsive to determining that the patient has achieved stable breathing while receiving the flow of treatment gas, the flow parameters are increased above the initial set of flow parameters with respect to a hyper-ventilation mode. The flow of treatment gas is then provided to the airway of the patient in accordance with the increased flow parameters for a predetermined period of time. The increased flow parameters are configured to bring the patient's breath into accordance with target patient breath parameters configured to inflate the patient's lungs beyond a threshold for activating pulmonary stretch receptors of the airway of the patient.

Concurrent treatment of obstructive sleep apnea and hypertension in a patient, via a pressure generating device, includes providing a flow of treatment gas to an airway of a patient in accordance with an initial set of flow parameters with respect to an obstructive sleep apnea mode. Responsive to determining that the patient has achieved stable breathing while receiving the flow of treatment gas, the flow parameters are increased above the initial set of flow parameters with respect to a hyper-ventilation mode. The flow of treatment gas is then provided to the airway of the patient in accordance with the increased flow parameters for a predetermined period of time. The increased flow parameters are configured to bring the patient's breath into accordance with target patient breath parameters configured to inflate the patient's lungs beyond a threshold for activating pulmonary stretch receptors of the airway of the patient.

Concurrent treatment of obstructive sleep apnea and hypertension in a patient, via a pressure generating device, includes providing a flow of treatment gas to an airway of a patient in accordance with an initial set of flow parameters with respect to an obstructive sleep apnea mode. Responsive to determining that the patient has achieved stable breathing while receiving the flow of treatment gas, the flow parameters are increased above the initial set of flow parameters with respect to a hyper-ventilation mode. The flow of treatment gas is then provided to the airway of the patient in accordance with the increased flow parameters for a predetermined period of time. The increased flow parameters are configured to bring the patient's breath into accordance with target patient breath parameters configured to inflate the patient's lungs beyond a threshold for activating pulmonary stretch receptors of the airway of the patient.

A system for ventilation of a being, comprising at least one ventilator and at least one EIT measuring device, the ventilator comprising at least one controllable respiratory gas source and a programmable control unit for controlling the respiratory gas source and the EIT measuring device comprising at least one sensor apparatus for measuring impedance values of at least one lung of the being and at least one calculation and evaluation unit, and the system assigning the impedance values measured by way of the at least one sensor apparatus to pixels n, and the control unit being configured as specified in the claims.

A system for ventilation of a being, comprising at least one ventilator and at least one EIT measuring device, the ventilator comprising at least one controllable respiratory gas source and a programmable control unit for controlling the respiratory gas source and the EIT measuring device comprising at least one sensor apparatus for measuring impedance values of at least one lung of the being and at least one calculation and evaluation unit, and the system assigning the impedance values measured by way of the at least one sensor apparatus to pixels n, and the control unit being configured as specified in the claims.

The present disclosure pertains to a system (10) configured to automatically set the positive end expiratory pressure (PEEP) during mechanical ventilation (800). The system uses a measured relationship between transpulmonary pressure and lung volume (804) to set PEEP (808) such that mechanically assisted breaths are delivered more effectively to open airways (e.g., tidal breaths will be delivered to airways that consist of alveoli that have not contracted or collapsed at the end of expiration) (810). Furthermore, the system is configured to sense (18, 804) when the lungs may be either hyperextended and/or undergoing cyclic atelectasis in order to prevent trauma or injury to the lung's fibrous tissue. The system is configured to perform recruitment and/or continuous monitoring and adjustment of the PEEP setting to maintain an open lung.

A method and device for developing an automated digital cloning method to create an accurate, predictive and personalized virtual patient model enabling personalized precision mechanical ventilation care.

Systems and methods for monitoring pulmonary edema and/or pulmonary congestion are based on changes in impedance parameters that are indicative of lung impedance of a patient. Early detection of changes in the status of a patient pertaining to pulmonary edema and/or pulmonary congestion may be especially beneficial for heart failure patients. Quantification is based on differentials, e.g. within a span of 24 hours, of one or more lung impedance parameters.

A ventilator for respiration gas supply, comprising a respiration gas source, a control unit, a memory, a pressure sensor and/or a flow sensor, an exchangeable respiration gas tube, at least one connection stub for the respiration gas tube, a patient interface and a valve. The control unit is set up to use signals from the pressure sensor and/or flow sensor to ascertain the patient's respiration phase and to ascertain the patient's current tidal volume during successive inhalations and exhalations and to compare a first set volume threshold for the tidal volume with the current tidal volume and to determine whether the latter is below the former and if so, to react by driving the respiration gas source to set a second pressure for the respiration gas for inhalation and driving the respiration gas source to set the CPAP pressure for the respiration gas for exhalation.